---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-009749"
form_type: "8-K"
ticker: "HTCR"
cik: "0001892322"
company_name: "HeartCore Enterprises, Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:49:16.339478+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# HeartCore Q4 revenue $2.0M, net loss $1.4M; full year net loss $6.7M

## Summary
- Q4 2022 revenue $2.0M (down from $2.4M YoY); net loss $1.4M ($0.08/diluted share) vs loss $742k ($0.05) YoY.
- Full year 2022 revenue $8.8M (down from $10.8M); net loss $6.7M ($0.37/diluted share) vs loss $327k ($0.02) YoY.
- Cash and equivalents $7.2M at Dec 31, 2022, up from $3.1M at Dec 31, 2021.
- Operational highlights: 903 enterprise customers; acquired 51% of Sigmaways; signed 9 Go IPO clients.
- CEO expects 2023 to be an inflection point; Go IPO client SBC Medical valued at $1.2B, warrants valued ~$32.4M.

## SEC filing metadata
- accession: 0001493152-23-009749
- form_type: 8-K
- ticker: HTCR
- cik: 0001892322
- company_name: HeartCore Enterprises, Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/0001493152-23-009749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-009749
- JSON: https://secwatch.observer/filing/0001493152-23-009749.json
- Plain text: https://secwatch.observer/filing/0001493152-23-009749.txt

## Key facts
- Earnings Releases
  HeartCore Enterprises, Inc. reported fourth quarter ended December 31, 2022 results: revenue $2.0 million, net income $1.4 million, or $0.08 per diluted share (net loss), EPS $0.08 per diluted share (net loss).
  - Period: fourth quarter ended December 31, 2022
  - Revenue: $2.0 million
  - Net income: $1.4 million, or $0.08 per diluted share (net loss)
  - EPS: $0.08 per diluted share (net loss)
  - Result: reported results
  source text: full year as a publicly traded company on the Nasdaq on a high note and expect 2023 to be an inflection point for HeartCore.” Fourth Quarter 2022 Financial Results Revenues were $2.0 million compared to $2.4 million in the same period last year. The decrease in revenues was due to lower sales of on-premise software and the effects of turbulence within the broader
  evidence_url: https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/0001493152-23-009749-index.htm
- Earnings Releases
  HeartCore Enterprises, Inc. reported full year ended December 31, 2022 results: revenue $8.8 million, net income $6.7 million (net loss), EPS $0.37 per diluted share (net loss).
  - Period: full year ended December 31, 2022
  - Revenue: $8.8 million
  - Net income: $6.7 million (net loss)
  - EPS: $0.37 per diluted share (net loss)
  - Result: reported results
  source text: share last year. The increase in net loss was primarily due to an increase in operating expenses and a decrease in revenues. Full Year 2022 Financial Results Revenues were $8.8 million compared to $10.8 million last year. The decrease in revenues was primarily due to a large, five-year CXM contract being renewed in 2021 and the ongoing depreciation of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/0001493152-23-009749-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.